These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 2907515)
1. Simultaneous determination of buspirone, gepirone, ipsapirone and their common metabolite 1-(2-pyrimidinyl)piperazine in rat plasma and brain by high-performance liquid chromatography. Bianchi G; Caccia S J Chromatogr; 1988 Oct; 431(2):477-80. PubMed ID: 2907515 [No Abstract] [Full Text] [Related]
2. The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP). Bianchi G; Caccia S; Della Vedova F; Garattini S Eur J Pharmacol; 1988 Jul; 151(3):365-71. PubMed ID: 2905658 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous high-performance liquid chromatographic analysis of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in plasma using electrochemical detection. Betto P; Meneguz A; Ricciarello G; Pichini S J Chromatogr; 1992 Mar; 575(1):117-21. PubMed ID: 1355487 [TBL] [Abstract][Full Text] [Related]
4. Kinetics, brain uptake, and receptor binding of tandospirone and its metabolite 1-(2-pyrimidinyl)-piperazine. Miller LG; Thompson ML; Byrnes JJ; Greenblatt DJ; Shemer A J Clin Psychopharmacol; 1992 Oct; 12(5):341-5. PubMed ID: 1362206 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine. Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663 [TBL] [Abstract][Full Text] [Related]
6. Effect of food on the bioavailability of gepirone in humans. Tay LK; Sciacca MA; Sostrin MB; Farmen RH; Pittman KA J Clin Pharmacol; 1993 Jul; 33(7):631-5. PubMed ID: 8103528 [TBL] [Abstract][Full Text] [Related]
7. Gepirone and 1-(2-pyrimidinyl)-piperazine-induced reduction of aversively evoked ultrasonic vocalisation in the rat. Cullen WK; Rowan MJ Pharmacol Biochem Behav; 1994 May; 48(1):301-6. PubMed ID: 7913229 [TBL] [Abstract][Full Text] [Related]
8. Determination of buspirone and 1-(2-pyrimidinyl)piperazine in plasma samples by high-performance liquid chromatography. Diaz-Marot A; Puigdellivol E; Salvatella C; Comellas L; Gassiot M J Chromatogr; 1989 May; 490(2):470-3. PubMed ID: 2768419 [No Abstract] [Full Text] [Related]
9. Interactions of buspirone with itraconazole and rifampicin: effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspirone. Kivistö KT; Lamberg TS; Neuvonen PJ Pharmacol Toxicol; 1999 Feb; 84(2):94-7. PubMed ID: 10068153 [TBL] [Abstract][Full Text] [Related]
10. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action. Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous quantitation of buspirone and its major metabolite 1-(2-pyrimidinyl)piperazine in human plasma by high-performance liquid chromatography with coulometric detection. Odontiadis J; Franklin M J Pharm Biomed Anal; 1996 Jan; 14(3):347-51. PubMed ID: 8851759 [TBL] [Abstract][Full Text] [Related]
12. Determination of buspirone and 1-(2-pyrimidinyl)-piperazine (1-PP) in human plasma by capillary gas chromatography. Kivistö KT; Laitila J; Mårtensson K; Neuvonen PJ Ther Drug Monit; 1999 Jun; 21(3):317-21. PubMed ID: 10365644 [TBL] [Abstract][Full Text] [Related]
13. Determination of plasma buspirone by high-performance liquid chromatography with coulometric detection. Franklin M J Chromatogr; 1990 Apr; 526(2):590-6. PubMed ID: 1972942 [No Abstract] [Full Text] [Related]
14. Simultaneous quantitation of buspirone and 1-(2-pyrimidinyl)piperazine in human plasma and urine by capillary gas chromatography-mass spectrometry. Sciacca MA; Duncan GF; Shea JP; Faulkner HC; Farmen RH; Pittman KA J Chromatogr; 1988 Jul; 428(2):265-74. PubMed ID: 3215930 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range. Dockens RC; Salazar DE; Fulmor IE; Wehling M; Arnold ME; Croop R J Clin Pharmacol; 2006 Nov; 46(11):1308-12. PubMed ID: 17050795 [TBL] [Abstract][Full Text] [Related]
18. Anticonflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1-(2-pyrimidinyl)piperazine. Przegalinski E; Tatarczynska E; Chojnacka-Wójcik E J Psychopharmacol; 1989 Jan; 3(3):180-5. PubMed ID: 22282903 [TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like activity of ipsapirone, buspirone and gepirone in the forced swimming test in rats pretreated with proadifen. Przegalinski E; Tatarczynska E; Chojnacka-Wójcik E J Psychopharmacol; 1990 Jan; 4(4):204-9. PubMed ID: 22281849 [TBL] [Abstract][Full Text] [Related]
20. Identification and quantitation of 1-(2-pyrimidinyl)piperazine, an active metabolite of the anxiolytic agent buspirone, in rat plasma and brain. Caccia S; Garattini S; Mancinelli A; Muglia M J Chromatogr; 1982 Dec; 252():310-4. PubMed ID: 7182413 [No Abstract] [Full Text] [Related] [Next] [New Search]